Miconazole nitrate
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Daktarin cream contains the active substance miconazole. Miconazole has antifungal effects, among others, on dermatophytes and yeast, as well as antibacterial effects on Gram-positive rods and cocci. Miconazole is also used to treat fungal infections that are secondarily infected. Miconazole usually eliminates skin itching, which often accompanies infections caused by dermatophytes and yeast. The itching disappears before other signs of healing appear.
Daktarin cream is indicated for the treatment of fungal skin infections caused by dermatophytes, yeast, and other fungi, such as: scalp ringworm, body ringworm, hand ringworm, and athlete's foot (tinea pedis). Due to its antibacterial effect, Daktarin cream may be used in fungal infections secondarily infected by bacteria (e.g., diaper rash).
Before starting to use Daktarin cream, discuss it with a doctor or pharmacist. If symptoms of an allergic reaction or skin irritation occur, treatment should be discontinued and a doctor consulted. Avoid contact between Daktarin cream and the eyes.
Tell your doctor about all the medicines you are taking now or have taken recently, as well as any medicines you plan to take. In patients taking oral anticoagulant medicines, such as warfarin, it is necessary to monitor the anticoagulant effect. The effects and side effects associated with the use of certain other medicines (e.g., oral medicines that lower blood sugar levels and phenytoin) may be intensified when used concurrently with Daktarin cream. Caution should be exercised when using other medicines.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before using this medicine. The doctor will weigh the potential risks and benefits to the mother and the fetus. It is not known whether the active substance of the medicine, miconazole, passes into breast milk. Therefore, Daktarin cream can be used in breastfeeding women only on the advice of a doctor.
No effects on the ability to drive or use machines have been observed.
Benzonic acid may cause local irritation. Benzonic acid may increase the risk of jaundice (yellowing of the skin and whites of the eyes) in newborns (up to 4 weeks of age).
The medicine may cause local skin reactions (e.g., contact dermatitis) or eye and mucous membrane irritation.
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist. If you are unsure, talk to a doctor or pharmacist.
Daktarin cream is applied to the affected areas of the skin, usually twice a day. If Daktarin cream is used at the same time as Daktarin medicated powder, it is recommended to use both forms of the medicine once a day. The duration of treatment is from 2 to 6 weeks, depending on the location and severity of the changes. After all symptoms and changes have disappeared, treatment should be continued for at least 1 week. If you feel that the effect of the medicine is too strong or too weak, talk to a doctor.
Using the medicine too frequently may cause skin irritation, which usually disappears after stopping the use of the medicine. If you accidentally swallow the medicine, contact a doctor immediately. Daktarin cream is intended for use on the skin only and should not be taken orally.
Do not use a double dose to make up for a missed dose.
If you have any further questions about the use of this medicine, talk to a doctor or pharmacist.
Like all medicines, Daktarin cream can cause side effects, although not everybody gets them. The frequency of possible side effects listed below is defined as: very rare (occur in less than 1 in 10,000 patients). After the medicine was placed on the market, very rare cases of allergic reactions, including severe reactions such as anaphylaxis and angioedema, urticaria, contact dermatitis, rash, erythema, itching, skin inflammation, pale spots on the skin, burning sensation on the skin, and local irritation, including irritation, burning, itching, and a feeling of warmth at the application site of Daktarin cream, have been reported.
If you get any side effects, talk to a doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl. By reporting side effects, you can help provide more information on the safety of this medicine.
Do not store above 25°C. Keep the medicine out of the sight and reach of children. Do not use Daktarin cream after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The pack contains a tube with 30 g of cream, placed in a cardboard box. For more detailed information, contact the marketing authorization holder or the parallel importer.
Johnson and Johnson Hellas Consumer S.A., Aigialeias and Epidavrou 4, Marousi, 151 25 Athens, Greece
Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź, Authorization number in Greece, the country of export: 8533/06-02-2007, 6792/12-02-2015
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.